Clinical trial Recruiting at 1 site Interventional Ages 12 to 18

Personalised nutrition tool for teens undergoing cancer treatment

Official title: Digital Innovation for Personalised Nutrition in Adolescent Oncology

Run by KU Leuven · NCT07865117 · Data updated 2026-11-12

A smartphone app called MybYte tests a tailored nutrition plan for teenagers aged 12–18 who are receiving cancer treatment to see if it is helpful and easy to use.

Quick facts

Study typeInterventional
Ages12 Years to 18 Years
SexAll
Enrollment30 (estimated)
SponsorKU Leuven
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Leuven, Vlaams Brabant)
StatusRecruiting
StartedSeptember 2026
Main results expectedMarch 2029
Study endsMarch 2029
Registry record updatedOctober 8, 2026
Trial IDNCT07865117 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Teenagers aged 12–18 who can use a smartphone, speak Dutch, and are receiving cancer treatment or recently diagnosed at KU Leuven / UZ Leuven.

Probably not a fit

Patients with cognitive, developmental, or neurological impairments that limit use of a digital tool or unable to provide assent/consent may not benefit from this tool.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project develops and tests MybYte, a digital nutrition tool for adolescents with cancer. It collects quick input on eating, appetite, and treatment-related symptoms and provides personalized nutrition guidance created by healthcare professionals. In Phase 1, about 15 teens help design and refine the tool through interviews and feedback. In Phase 2, about 15 newly diagnosed teens will use MybYte for one week each month over six months while standard nutrition assessments occur. The study aims to determine whether MybYte is acceptable, practical, and potentially beneficial for teenagers undergoing cancer treatment.

Why it matters

Potential benefit: If successful, MybYte could support better nutrition management and Quality of Life for adolescent cancer patients by providing personalized guidance through a mobile interface.

How similar studies have gone: Prior digital nutrition tools have shown feasibility in pediatric populations, but this exact adolescent cancer-focused, co-designed MybYte approach is exploratory in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Written informed consent has been obtained from a parent/legal guardian.
* Written assent has been obtained from participants.
* Aged between 12 and 18 years at the time of enrolment.
* Ability to use a smartphone independently.
* Adequate cognitive capacity to participate in study procedures, as determined by the research team.
* Proficiency in Dutch
* For Phase 1:
* Currently receiving, or having previously received cancer treatment (including chemotherapy) at University Hospitals Leuven within the specified age range.
* For Phase 2:
* New histological diagnosis of cancer
* Enrolled into the study within 6 weeks of diagnosis.
* Currently receiving cancer treatment (including chemotherapy) at University Hospitals Leuven.

Exclusion Criteria Phase 1 and 2:

* Presence of cognitive, developmental, or neurological impairments that compromise the ability to provide informed consent or assent, or that impair \\ independent use of a digital tool
* Medical instability or clinical condition deemed too unwell for participation, as determined by the treating clinician.
* Admitted to the intensive care unit during the enrollment period.
* Currently on a palliative care trajectory.

Where it's running

  • University Hospitals Leuven (UZ Leuven)
    Leuven, Vlaams Brabant, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.